From July 1, 2023 to September 30, 2023, the company has repurchased 149,041 shares, representing 0.48% for $0.17 million. With this, the company has completed the repurchase of 4,708,520 shares, representing 14.3% for $15.42 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 USD | +5.41% | +1.74% | -12.03% |
Apr. 12 | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event | CI |
Apr. 04 | Co-Diagnostics, Inc. Appoints Executive Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.03% | 36.57M | |
-13.57% | 19.22B | |
-46.59% | 2.63B | |
+17.50% | 1.86B | |
-0.58% | 1.66B | |
+26.03% | 1.23B | |
-8.67% | 1.05B | |
-21.91% | 894M | |
-3.24% | 740M | |
-17.51% | 687M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.